Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium–Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.

MLA

Gupta, Kashvi, et al. “Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium–Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.” Circulation, vol. 148, no. 3, July 2023, pp. 220–28. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.122.063263.

APA

Gupta, K., Spertus, J. A., Birmingham, M., Gosch, K. L., Husain, M., Kitzman, D. W., Pitt, B., Shah, S. J., Januzzi, J. L., Lingvay, I., Butler, J., Kosiborod, M., & Lanfear, D. E. (2023). Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium–Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials. Circulation, 148(3), 220–228. https://doi.org/10.1161/CIRCULATIONAHA.122.063263

Chicago

Gupta, Kashvi, John A. Spertus, Mary Birmingham, Kensey L. Gosch, Mansoor Husain, Dalane W. Kitzman, Bertram Pitt, et al. 2023. “Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium–Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.” Circulation 148 (3): 220–28. doi:10.1161/CIRCULATIONAHA.122.063263.